# Neuroimmune Response to Lipopolysaccharide

> **NCT04233593** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Lipopolysaccharide

## Key facts

- **NCT ID:** NCT04233593
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-25
- **Primary completion:** 2021-08-17
- **Final completion:** 2021-08-17
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04233593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04233593, "Neuroimmune Response to Lipopolysaccharide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04233593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*